Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites.

Bai A, Bielawska A, Rahmaniyan M, Kraveka JM, Bielawski J, Hannun YA.

Bioorg Med Chem. 2018 Dec 15;26(23-24):6067-6075. doi: 10.1016/j.bmc.2018.11.012. Epub 2018 Nov 10.

PMID:
30448190
2.

Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.

Boppana NB, Kraveka JM, Rahmaniyan M, Li LI, Bielawska A, Bielawski J, Pierce JS, Delor JS, Zhang K, Korbelik M, Separovic D.

Anticancer Res. 2017 Feb;37(2):455-463.

3.

The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.

Venant H, Rahmaniyan M, Jones EE, Lu P, Lilly MB, Garrett-Mayer E, Drake RR, Kraveka JM, Smith CD, Voelkel-Johnson C.

Mol Cancer Ther. 2015 Dec;14(12):2744-52. doi: 10.1158/1535-7163.MCT-15-0279. Epub 2015 Oct 22.

4.

Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.

Separovic D, Breen P, Boppana NB, Van Buren E, Joseph N, Kraveka JM, Rahmaniyan M, Li L, Gudz TI, Bielawska A, Bai A, Bielawski J, Pierce JS, Korbelik M.

Int J Oncol. 2013 Dec;43(6):2064-72. doi: 10.3892/ijo.2013.2132. Epub 2013 Oct 9.

5.

Prediction of neonates' macrosomia with maternal lipid profile of healthy mothers.

Mossayebi E, Arab Z, Rahmaniyan M, Almassinokiani F, Kabir A.

Pediatr Neonatol. 2014 Feb;55(1):28-34. doi: 10.1016/j.pedneo.2013.05.006. Epub 2013 Aug 2.

6.

Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.

Breen P, Joseph N, Thompson K, Kraveka JM, Gudz TI, Li L, Rahmaniyan M, Bielawski J, Pierce JS, VAN Buren E, Bhatti G, Separovic D.

Anticancer Res. 2013 Jan;33(1):77-84.

7.

Cell density-dependent reduction of dihydroceramide desaturase activity in neuroblastoma cells.

Spassieva SD, Rahmaniyan M, Bielawski J, Clarke CJ, Kraveka JM, Obeid LM.

J Lipid Res. 2012 May;53(5):918-28. doi: 10.1194/jlr.M019075. Epub 2012 Feb 29.

8.

Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide.

Rahmaniyan M, Curley RW Jr, Obeid LM, Hannun YA, Kraveka JM.

J Biol Chem. 2011 Jul 15;286(28):24754-64. doi: 10.1074/jbc.M111.250779. Epub 2011 May 4.

9.

Dihydroceramide desaturase activity is modulated by oxidative stress.

Idkowiak-Baldys J, Apraiz A, Li L, Rahmaniyan M, Clarke CJ, Kraveka JM, Asumendi A, Hannun YA.

Biochem J. 2010 Mar 29;427(2):265-74. doi: 10.1042/BJ20091589.

10.

Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase.

Rahmaniyan M, Patrick K, Bell NH.

Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E753-60. Epub 2004 Dec 7.

Supplemental Content

Loading ...
Support Center